Virtual Medicinal Product (VMP)
-
Tafamidis meglumine 20mg capsules
Name Details
Current Name
Tafamidis meglumine 20mg capsules
|
Start Date
30-06-2020
|
End Date
|
Previous Name
Tafamidis 20mg capsules
|
Start Date
05-03-2013
|
End Date
29-06-2020
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N07XX08
BNF |
Current BNF
04090300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04090300
|
Start Date
25-09-2013
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
22155011000001108 |
05-03-2013 |
|
VMP Ingredients
Name
Tafamidis meglumine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
Parent Products
-
VTM
Tafamidis
-
VMP
(Current) Tafamidis meglumine 20mg capsules
Virtual Medicinal Product Pack (VMPP) Information